Use of MHC II Structural Features in the Design of Vaccines for Organ-Specific Autoimmune Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|28|3262-3273

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.28, 2009-10, pp. : 3262-3273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Approach to Immunotherapy Against Organ-specific Autoimmune Diseases with T Cell Receptor and Chemokine Receptor DNA Vaccines

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 1, 2005-03 ,pp. : 73-77

Bentham Science Publishers

Access to resources Recommend Favorite

MHC ligands as potential therapeutics in the treatment of autoimmune and allergic diseases

By Guichard G.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. : 29-42

Informa Healthcare

Access to resources Recommend Favorite

BUILDING AN ORGAN-SPECIFIC CARCINOGENIC DATABASE FOR SAR ANALYSES

By Young John   Tong Weida   Fang Hong   Xie Qian   Pearce Bruce   Hashemi Ray   Beger Richard   Cheeseman Mitchell   Chen James   Chang Yuan-chin   Kodell Ralph  

Journal of Toxicology and Environmental Health, Vol. 67, Iss. 17, 2004-09 ,pp. : 1363-1389

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Use of 3D Structural Data in the Design of Specific Factor Xa Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-06 ,pp. : 161-174

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Expression of MHC Class II Molecules in Autoimmune Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 2, 2004-01 ,pp. : 129-143

Bentham Science Publishers

Access to resources Recommend Favorite